论文部分内容阅读
2015年9月2日 世界卫生组织和世界肝炎联盟共同组织的世界肝炎峰会今天在苏格兰城市格拉斯哥拉开帷幕，这是全球首次专门针对病毒性肝炎召开的高级别会议。与会代表将在为期3天的会议上敦促各国制定国家规划，力争消除病毒性肝炎。会议旨在促进各国为预防病毒性肝炎感染采取行动，确保患者得到诊断和治疗。
世界卫生组织全球肝炎规划主任赫恩斯查尔（Gottfried Hirnschall）指出，这次峰会的重要性在于提高人们的意识，敦促各国将病毒性肝炎作为一项公共卫生问题加以预防、诊断、治疗并最终予以消除。
来自60多个国家的政府官员、病人团体、内科医生和其它主要利益攸关方将在会议上讨论世卫组织病毒性肝炎问题全球卫生部门战略草案，包括在2030年前将慢性乙肝和丙肝的新发病例减少90%，将丙肝和乙肝死亡减少65%，对80%的符合要求的慢性乙肝和丙肝感染者进行治疗。世卫组织将在本次峰会上发布一份制定并评估国家病毒性肝炎计划的新手册。
目前约有4亿人属于病毒性肝炎携带者，估计该病每年使145万人死亡，是世界上的主要死亡原因之一。乙肝和丙肝约占所有肝癌死亡人数的80%，但多数慢性病毒性肝炎携带者并不了解其感染状况。
在撒哈拉以南非洲和东亚，约有5%至10%的人口属于乙肝慢性感染者，亚马逊和中、东欧南部地区亦为慢性感染高发区。丙型肝炎在世界各地均有发生，非洲、中亚和东亚地区的感染率较高，注射吸毒者中约有三分之二染有丙肝。
2 September 2015 The World Hepatitis Summit co-sponsored by World Health Organization and World Hepatitis Alliance opens at Glasgow， Scotland. This is also the first global high-level meeting on viral hepatitis. In three-day agenda， delegates urge governments to make plans. This meeting aims to ensure governments to agree on global targets for prevention， diagnosis and treatment.
Dr. Gottfried Hirnschall， Director of the WHO’s Global Hepatitis Programme pointed out that this summit is a wake-up call to build momentum to prevent， diagnose， treat-and eventually eliminate viral hepatitis as a public health problem.
Policymakers， patient groups， physicians and other key stakeholders from more than 60 countries are expected to discuss a draft strategy paper including a 90% reduction in new cases of chronic hepatitis B and C， a 65% reduction in hepatitis B and C deaths， and treatment of 80% of eligible people with chronic hepatitis B and C infections by 2030. WHO is launching a new manual for the development and assessment of national viral hepatitis plans at the summit.
Now， about 400 million people are currently living with viral hepatitis， and the disease claims an estimated 1.45 million lives each year， making it one of the world’s leading causes of death. Hepatitis B and C cause approximately 80 per cent of all liver cancer deaths， yet most people living with chronic viral hepatitis are unaware of their infection.
In sub-Saharan Africa and East Asia between 5-10% of the population is chronically infected with hepatitis B. High rates of chronic infections are also found in the Amazon and the southern parts of eastern and central Europe. Hepatitis C is found worldwide. Infection rates are high in Africa and Central and East Asia， and approximately two-thirds of people who inject drugs are infected with hepatitis C.
http：//www.un.org/chinese/News/story.asp？NewsID=24647
世界卫生组织全球肝炎规划主任赫恩斯查尔（Gottfried Hirnschall）指出，这次峰会的重要性在于提高人们的意识，敦促各国将病毒性肝炎作为一项公共卫生问题加以预防、诊断、治疗并最终予以消除。
来自60多个国家的政府官员、病人团体、内科医生和其它主要利益攸关方将在会议上讨论世卫组织病毒性肝炎问题全球卫生部门战略草案，包括在2030年前将慢性乙肝和丙肝的新发病例减少90%，将丙肝和乙肝死亡减少65%，对80%的符合要求的慢性乙肝和丙肝感染者进行治疗。世卫组织将在本次峰会上发布一份制定并评估国家病毒性肝炎计划的新手册。
目前约有4亿人属于病毒性肝炎携带者，估计该病每年使145万人死亡，是世界上的主要死亡原因之一。乙肝和丙肝约占所有肝癌死亡人数的80%，但多数慢性病毒性肝炎携带者并不了解其感染状况。
在撒哈拉以南非洲和东亚，约有5%至10%的人口属于乙肝慢性感染者，亚马逊和中、东欧南部地区亦为慢性感染高发区。丙型肝炎在世界各地均有发生，非洲、中亚和东亚地区的感染率较高，注射吸毒者中约有三分之二染有丙肝。
2 September 2015 The World Hepatitis Summit co-sponsored by World Health Organization and World Hepatitis Alliance opens at Glasgow， Scotland. This is also the first global high-level meeting on viral hepatitis. In three-day agenda， delegates urge governments to make plans. This meeting aims to ensure governments to agree on global targets for prevention， diagnosis and treatment.
Dr. Gottfried Hirnschall， Director of the WHO’s Global Hepatitis Programme pointed out that this summit is a wake-up call to build momentum to prevent， diagnose， treat-and eventually eliminate viral hepatitis as a public health problem.
Policymakers， patient groups， physicians and other key stakeholders from more than 60 countries are expected to discuss a draft strategy paper including a 90% reduction in new cases of chronic hepatitis B and C， a 65% reduction in hepatitis B and C deaths， and treatment of 80% of eligible people with chronic hepatitis B and C infections by 2030. WHO is launching a new manual for the development and assessment of national viral hepatitis plans at the summit.
Now， about 400 million people are currently living with viral hepatitis， and the disease claims an estimated 1.45 million lives each year， making it one of the world’s leading causes of death. Hepatitis B and C cause approximately 80 per cent of all liver cancer deaths， yet most people living with chronic viral hepatitis are unaware of their infection.
In sub-Saharan Africa and East Asia between 5-10% of the population is chronically infected with hepatitis B. High rates of chronic infections are also found in the Amazon and the southern parts of eastern and central Europe. Hepatitis C is found worldwide. Infection rates are high in Africa and Central and East Asia， and approximately two-thirds of people who inject drugs are infected with hepatitis C.
http：//www.un.org/chinese/News/story.asp？NewsID=24647